USPTO serial 98354567
CAREGENEX
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- AYALA, LOURDES
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CAREGENEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,444*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Somerset, NJ, US
Somerset, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rosaleen H. Chou
Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific and research use; Reagents for use in gene analysis and sequencing; Reagents for use in DNA and RNA analysis and sequencing; Reagents for in vitro use in biochemistry and cell culture reagents for scientific and research use; Reagents for scientific and research use in the fields of gene analysis and sequencing, DNA analysis and sequencing, and RNA analysis and sequencing; Reagents for use in gene analysis and sequencing as well as DNA and RNA analysis and sequencing, namely, polymerase chain reaction (PCR) master mixes, polymerase chain reaction (PCR) reagents and enzymes, polymerase chain reaction (PCR) test kits containing DNA primers and template control DNA for polymerase chain reaction (PCR), all for scientific and research use; Biochemical reagents used for non-medical purposes; Diagnostic tests and testing kits primarily composed of reagents for scientific and research use purposes; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations used for non-medical purposes; Testing kits comprised primarily of reagents and assays for scientific or research use in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases | ACTIVE | — |
| 005 | Diagnostic reagents for medical use; Medical diagnostic reagents and assays for diagnostic testing of medical samples for microorganisms, pathogens, genotypes, and viruses; Reagents for medical diagnostic use used in gene analysis and sequencing as well as DNA and RNA analysis and sequencing, namely, polymerase chain reaction (PCR) master mixes, polymerase chain reaction (PCR) reagents and enzymes, polymerase chain reaction (PCR) test kits containing DNA primers and template control DNA for polymerase chain reaction (PCR), all for medical diagnostic use; Diagnostic biomarker reagents for medical purposes; Reagents for medical diagnostic use used in the collection, storage and preparation of materials for gene analysis and sequencing as well as DNA and RNA analysis and sequencing, and in DNA extraction systems for crude lysates, DNA purification systems and cell filtration systems, diagnostic biomarker reagents for medical purposes, diagnostic reagents for medical use, medical diagnostic reagents for the analysis of body fluids, and medical diagnostic reagents and assays for testing body fluids for microorganisms; Reagents for medical diagnostic use used in detecting pathogens and genetic mutations, namely, testing kits for medical diagnostic use containing one or more of polymerase chain reaction (PCR) reagents, polymerase chain reaction (PCR) primers, cell culture medias, and diagnostic reagents and assays for diagnostic testing of medical samples for microorganisms, pathogens, genotypes, and viruses; Diagnostic reagents and consumables, namely, polymerase chain reaction (PCR) master mixes, polymerase chain reaction (PCR) reagents and enzymes, polymerase chain reaction (PCR) test kits containing DNA primers and template control DNA for polymerase chain reaction (PCR), for medical diagnostic use used in connection with polymerase chain reaction (PCR), molecular diagnostics, and gene analysis; Chemical preparations in the nature of medical diagnostic reagents for testing nucleic acid analysis, for medical use; Medical diagnostic reagents, assays, chemical reagents and kits consisting primarily of medical diagnostic reagents, assays, chemical reagents for medical testing and diagnostic purposes; Medical diagnostic reagents, and kits comprised of medical diagnostic reagents, collection tubes, buffers, tube holders, transport bags, and instruction sheets, for diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Diagnostic testing kits and assays for use in medical, clinic, and companion diagnostic testing in the fields of medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases | ACTIVE | — |
| 009 | Research laboratory instrument for extracting and purifying DNA and RNA from samples; DNA amplification apparatus, namely, thermocyclers for scientific or medical research use; Downloadable software for use with thermocyclers and DNA amplification devices for use in conducting analysis of real-time polymerase chain reaction (PCR) data; Downloadable software for use in DNA and RNA analysis and sequencing, detection of genetic mutations, and detection of pathogens; Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of pathogens, not for medical purposes; Downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; Computer hardware and downloadable and recorded computer software for use in data analysis in the fields of medical, clinical, and companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases | ACTIVE | — |
| 010 | Apparatus and instruments for testing, analysis and diagnosis of samples, namely, medical diagnostic apparatus for testing DNA and RNA samples; DNA amplification apparatus, namely, thermocyclers for DNA and RNA testing for medical purposes; Medical apparatus for use in extracting DNA and RNA; Sample preparation device for medical diagnostic use; Medical apparatus for conducting polymerase chain reactions; Medical apparatus for conducting quantitative or real-time polymerase chain reactions; Quantitative PCR machines for conducting quantitative or real-time polymerase chain reactions; Medical equipment, namely, sample containers in the nature of containers for medical waste, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use, blood containers for medical purposes sold empty, medical sample vials, dropping pipettes and magnetic stirrers used in the preparation of samples for testing; Kits comprising of medical sample vials, reagents and instructions for the preparation of samples for polymerase chain reaction (PCR) testing for medical purposes; Medical equipment, namely, racks for holding samples and vials during testing; Replacement and structural parts, fittings and accessories in the nature of capillary reagent tubes for medical use, medical sample tubes and vials for all the aforesaid goods | ACTIVE | — |
| 042 | Research and development in the fields of biologics and biotechnology; Medical research laboratories; Biological research and analysis; Biochemical research and analysis; Biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis for scientific or research purposes | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes provided by medical laboratories | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Access Bio, Inc.
- Other trademarks owned by Access Bio, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CAREGENEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 15, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 15, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 15, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 11, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 11, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 11, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 20, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 25, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 25, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 19, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 21, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Nov 21, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2024 | NWAP | NEW APPLICATION ENTERED | — |